- Directions for use
- Sincerus Florida. Adverse reactions
- Active, inactive
- NDC 72934-1127-2 IMIQUIMOD USP 5% / NIACINAMIDE USP 4%. Gel 30 gm
-
INGREDIENTS AND APPEARANCE
IMIQUIMOD 5% / NIACINAMIDE 4%
imiquimod 5% / niacinamide 4% gelProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-1127 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 4 g in 100 g IMIQUIMOD (UNII: P1QW714R7M) (IMIQUIMOD - UNII:P1QW714R7M) IMIQUIMOD 5 g in 100 g Product Characteristics Color white Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-1127-2 30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/07/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/07/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-1127)